超声引导下8G真空辅助旋切治疗精选B3乳腺病变的初步经验
本研究评估超声引导下真空辅助旋切(US-VAE)治疗精选B3乳腺病变的可行性与疗效,2018年7月至2019年12月共治疗11/48个B3病变,完全切除率81.8%,无病变升级为癌、无患者需手术、无并发症,患者满意度100%,每次操作费用约422欧元。
要点
- US-VAE对精选B3乳腺病变完全切除率81.8%,无升级为癌、无手术、无并发症。
- 12个月超声作为评估切除完整性的金标准。
- 患者对操作及美容效果满意度100%,每次操作费用约422欧元。
核心结论
- US-VAE被证明是精选B3乳腺病变治疗性切除的优化工具,成功率高、患者依从性好且较手术显著节省费用,该技术有潜力减少不必要的手术和医疗支出。
研究设计与样本
- 前瞻性初步经验研究,2018年7月至2019年12月在本机构对超声引导下空心针活检诊断为B3的48个乳腺病变中的11个行US-VAE治疗。
诊断标准与关键数值
- 纳入标准为国际指南推荐行VAE的超声可检出B3结节、大小5–25 mm、边缘清晰、病变距皮肤和乳头至少5 mm;12个月超声为评估切除完整性的金标准。
临床应用与阅片要点
- 术后10天、30天、6个月和12个月行影像随访评估切除完整性、术后血肿或残留/复发;所有患者完成满意度调查并进行US-VAE全程费用评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Nowadays, surgical excision is no longer justified for all B3 lesions and a minimally-invasive therapeutic treatment has been encouraged. The aim of this study was to evaluate the feasibility and the therapeutic efficacy of ultrasound-guided vacuum-assisted excision (US-VAE) for the treatment of selected breast lesions of uncertain malignant potential (B3).
MATERIAL AND METHODS: From July 2018 to December 2019, 11/48 breast lesions classified as B3 after ultrasound-guided core needle biopsy were treated with US-VAE in our Institution. Inclusion criteria were: B3 nodules ultrasonographically detectable for which VAE is recommended by international guidelines2, size ranging between 5 and 25 mm, circumscribed margins, and lesion position at least 5 mm from the skin and the nipple. A radiological follow-up to evaluate the completeness of excision, the presence of post-procedural hematoma or of residual disease/recurrence was performed after 10 and 30 days and 6 and 12 months. 12-month ultrasound was considered the gold standard. All patients were asked to complete a satisfaction survey and a full assessment of the costs of US-VAE was performed.
RESULTS: Complete excision was achieved in 81.8% of US-VAE. No lesions were upgraded to carcinoma and no patients had to undergo surgery. No complications occurred during or after US-VAE. All patients were satisfied with the procedure and the cosmetic result (100%). US-VAE cost approximately 422 Euros per procedure.
CONCLUSION: US-VAE has proven to be an optimal tool for the therapeutic excision of selected B3 lesions, with high success rate, good patient compliance and considerable money savings compared to surgery. This technique has the potential to reduce unnecessary surgery and healthcare costs.
引用
- Panzironi, Moffa, Galati, et al. Ultrasound-guided 8-Gauge vacuum-assisted excision for selected B3 breast lesions: a preliminary experience. Radiol Med. 2021. PMID: 34800217. doi:10.1007/s11547-021-01429-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。